Many individuals from a range of backgrounds and specialties have contributed to the development of this guidance. WHO is sincerely grateful for their time and support.
Guidelines Development Group
The chairs of the Guidelines Development Group were Indri Oktaria Sukmaputri (Ministry of Health, Indonesia) and Ramatoulie Njie (International Agency for Research on Cancer (IARC), Republic of the Gambia). Roger Chou (Oregon Health & Science University, USA) was the guidelines methodologist.
The following experts served on the Guidelines Development Group: Rakesh Aggarwal (Jawaharlal Institute of Postgraduate Medical Education and Research, India); Benjamin Cowie (The Peter Doherty Institute for Infection and Immunity, Australia); Manal El-Sayed (Ain Shams University, Egypt); Fernanda Fernandes Fonseca (Ministry of Health, Brazil); Alice Guingané (Centre Hospitallier Universitaire Ougadougou, Burkina Faso); Gonzague Jourdain (French National Research Institute for Sustainable Development, France; Chiang Mai University, Thailand); Elizabeth Mason (University College London, United Kingdom); Hiromi Obara (National Center for Global Health and Medicine, Japan); Deborah Odoh (Ministry of Health, Nigeria); Huma Qureshi (Pakistan Health Research Council, Pakistan); Olivier Segeral (Agence Nationale de Recherche sur le Sida et les hépatites virales, Cambodia); Sarah Schillie (Centers for Disease Control and Prevention, USA); Su Wang (Center for Asian Health, USA); Cihan Yurdaydin (Koc University Medical School, Turkey).
External peer review group
The following experts served as external peer reviewers of the draft guidelines document: Adele Benzaken (AIDS Healthcare Foundation, Brazil), Nikoloz Chkhartishvili (Infectious Diseases, AIDS and Clinical Immunology Research Center, Georgia), Merceline Dahl-Regis (Ministry of Health, the Bahamas), Serge Eholie (Treichville University Teaching Hospital, Côte d’Ivoire), Shaffiq Essajee (UNICEF, USA), Xu Fujie (Zhejiang University, China), Zheng Hui (Chinese Center for Disease Control and Prevention, China), Michelle Giles (Monash University, Australia), Kathy Jackson (Victorian Infectious Diseases Reference Laboratory, Australia), Karen Kyuregyan (Ministry of Health, Russia), Alice Lee (Hepatitis B free, Australia), Seng Gee Lim (National University Hospital, Singapore), Maya Malarski (Gavi, The Vaccine Alliance, Switzerland), Christian Ramers (Clinton Health Access Initiative [CHAI], USA), Samuel So (Stanford University, USA), Mark Sonderup (University of Cape Town, South Africa), Takeshi Terashima (Kanazawa University, Japan), Gilles Wandeler (University of Bern, Switzerland).
WHO Steering Group
Marc Bulterys, Philippa Easterbrook, Yvan Hutin, Judith van Holten, Morkor Newman (Global HIV, Hepatitis and Sexually Transmitted Infections Programmes), Shalini Desai (Expanded Programme on Immunization), Melanie Taylor (Reproductive Health and Research), Anne Brink, Naoko Ishikawa, Po-Lin Chan (WHO Regional Office for the Western Pacific), Julien Kabore, Lesi Olufunmilayo (WHO Regional Office for Africa), Leandro Sereno (WHO Regional Office for the Americas).
WHO staff and consultants
The following WHO staff and consultants contributed to developing these guidelines: Marc Bulterys, Philippa Easterbrook, Cui Fuqiang, Yvan Hutin, Judith van Holten (Global HIV, Hepatitis and Sexually Transmitted Infections Programmes), Oyuntungalag Namjilsuren (Communications support), Po-Lin Chan (WHO Regional Office for the Western Pacific), Joumana Hermez (WHO Regional Office for the Eastern Mediterranean), Olufunmilayo Lesi (WHO Regional Office for Africa), Antons Mozalevskis (Regional Office for Europe), BB Rewari (WHO Regional Office for South-East Asia), Leandro Sereno (WHO Regional Office for the Americas), Lydia Kawanguzi and Laurent Poulain provided administrative support.
Overall coordination and writing
Judith van Holten coordinated the overall guidelines development process and drafted the document, supervised by Marc Bulterys and Yvan Hutin, and under the leadership of Andrew Ball.
Editing
The final draft was edited by Bandana Malhotra.
Evidence review teams
We would like to credit the following researchers for conducting the systematic reviews, evidence profiles and GRADE tables for the recommendations: Yusuke Shimakawa, Pauline Boucheron, Anna Funk (Institut Pasteur, France), Ying Lu, Tianshuo Zhao (Peking University, China) and Kyoko Yoshida (Tokyo Medical and Dental University, Japan).
Modelling
Modelling on the impact and cost–effectiveness was done by Shevanthi Nayagam and Timothy Hallett (Imperial College London, UK).
Funding
Funding for the development of these guidelines was provided by the Government of Germany and by the United States Centers for Disease Control and Prevention.
